Medicines and biologics themselves are referred to as pharmaceuticals. This term covers the substances used to diagnose, treat, prevent, or manage diseases, including vaccines, antibiotics, and hormonal therapies. They are distinct from the other categories because those names describe types of waste generated in healthcare settings—cytotoxic waste involves hazardous drug residues, pathological waste includes tissues or body parts, and radioactive medical waste contains radioactive materials from certain procedures. Understanding that pharmaceuticals describe the drugs and biologics themselves helps keep the focus on the products used in patient care rather than the waste streams they may become.

This question tests how policy drives the adoption of health information technology and the protection of electronic health data. The law that does both—promoting widespread use of electronic health records through incentives and establishing meaningful use criteria, while also strengthening privacy and security provisions for electronic health information—is the Health Information Technology for Economic and Clinical Health Act. It was created to accelerate the adoption of EHRs and to formalize meaningful use, guiding how providers demonstrate the effective use of digital records. At the same time, it expanded and reinforced HIPAA’s privacy and security rules—tightening breach notifications and enforcement—so that electronic data have stronger protections as their use expands. HIPAA, by itself, set baseline privacy and security standards but didn’t include the incentives SAMPLEor the specific meaningful use framework. The other options aren’t recognized federal laws that target EHR adoption or the expanded privacy/security framework in this integrated way.

Public health is the field that focuses on protecting and improving the health of entire communities through prevention, policy, education, and research. It works at the population level rather than just treating individual patients, aiming to prevent illness before it starts and to promote healthier environments for everyone. Think of efforts like vaccination campaigns, clean water and sanitation standards, policies that reduce tobacco use, and programs that promote healthy lifestyles. These activities rely on educating the public, enacting smart policies, studying health trends, and delivering preventive care to communities. Medicine, by contrast, centers on diagnosing and treating illnesses in individual patients, while private healthcare refers to care delivered within private settings or systems, and a stakeholder is any person or group with an interest in an outcome.

Non-maleficence centers on the obligation to avoid causing harm to patients. It’s the principle captured by “do no harm,” guiding decisions to minimize unnecessary pain, injury, or suffering that could come from treatment. This is why the option describing avoiding harm and unnecessary harm is the best fit. The other concepts describe related duties in different ways: maximizing benefits reflects beneficence (doing good for the patient), respecting autonomy focuses on honoring the patient’s choices, and ensuring equal access aligns with justice (fair distribution of care).